Development and validation of a LC-MS quantification method for the lantibiotic MU1140 in rat plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 4, 2009, Pages 970-975

  Ghobrial, Oliver G ^a,b   Derendorf, Hartmut ^b   Hillman, Jeffrey D ^a  

^a Oragenics Inc   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Lantibiotic; LC MS; MU1140; Quantification

Indexed keywords

GALLIDERMIN; LANTIBIOTIC; LANTIBIOTIC MU1140; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STABILITY; FREEZE THAWING; ION MONITORING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; STANDARD;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTERIOCINS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FREEZING; HALF-LIFE; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDES; QUALITY CONTROL; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 62749163778     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.12.022     Document Type: Article

References (10)

1. http://www.fda.gov/oc/opacom/hottopics/antiresist_facts.html, F.
2. Silver L.L., and Bostian K.A. Antimicrob. Agents Chemother. 37 (1993) 377-383
3. Hillman J.D., Novak J., Sagura E., Gutierrez J.A., Brooks T.A., Crowley P.J., Hess M., Azizi A., Leung K., Cvitkovitch D., and Bleiweis A.S. Infect Immun. 66 (1998) 2743-2749
4. Smith L., Zachariah C., Thirumoorthy R., Rocca J., Novak J., Hillman J.D., and Edison A.S. Biochemistry 42 (2003) 10372-10384
5. Hasper H.E., Kramer N.E., Smith J.L., Hillman J.D., Zachariah C., Kuipers O.P., de Kruijff B., and Breukink E. Science 313 (2006) 1636-1637
6. Rogers L.A. J. Bacteriol. 16 (1928) 321-325
7. Cotter P.D., Hill C., and Ross R.P. Curr. Protein Pept. Sci. 6 (2005) 61-75
8. Ghobrial O.G., Derendorf H., and Hillman J.D. Int J Antimicrob. Agents 33 (2009) 70-74
9. Nowatzke W., and Woolf E. AAPS J. 9 (2007) E117-E122
10. U.S. Department of Health and Human Services Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation, http://www.fda.gov/ CDER/GUIDANCE/4252fnl.htm, 2001, 27-2-2007.